RE: Strong week, Strong close18 Jul 2025 23:06
FAB have tested my patience for 2 years. They are fundamentally wrongly valued, but I think this is a historical abberation resulting from the deeply discounted placing in May 2023. They have not essentially recovered at all from that , yet they are in a totally much better place . They have the large grant, non dilutive funding, access to Queens Research facilities, NCI agreement. They are one RNS and could be a £100m plus company easily if their tech is patented by NCI and antibodies are researched. It sounds I am hopeful, yet over the years 100s of companies have frustrated for long periods, then suddenly rerated as the market wakes up to their potential. FAB seem to be almost there now